Ceronapril

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Ceronapril
Ceronapril.svg
Clinical data
AHFS/Drugs.comMonograph
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC30H46NO7P
Molar mass563.663 g/mol g·mol−1
3D model (JSmol)

Ceronapril (INN,[1] proposed trade names Ceranapril, Novopril) in a phosphonate ACE inhibitor[2] that was never marketed.

References[edit]

  1. ^ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 31" (PDF). World Health Organization. p. 4. Retrieved 2 March 2017.
  2. ^ Tu, JI; Brennan, J; Stouffer, B; Mantha, S; Turabi, N; Tsay, HM (June 1992). "Radioimmunoassay for Ceronapril, a New Angiotensin-Converting Enzyme Inhibitor, and Its Application to a Pharmacokinetic Study in Healthy Male Volunteers". Therapeutic Drug Monitoring. 14 (3): 209–19. PMID 1412607.